Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.870
+0.030 (1.63%)
Nov 28, 2025, 1:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Rare Disease Therapies
12.43M